The influence of a chondroitinsulphate preparation on experimental atherosclerosis in rabbits.
D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology*; D001018:Aortic Diseases / Q000473:pathology; D001161:Arteriosclerosis / Q000473:pathology / Q000517:prevention & control*; D001777:Blood Coagulation / Q000187:drug effects; D002784:Cholesterol / Q000494:pharmacology; D002791:Cholesterol, Dietary; D002807:Chondroitin / Q000494:pharmacology*; D004036:Diet, Atherogenic; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D008055:Lipids / Q000097:blood; D011817:Rabbits
D000924:Anticholesteremic Agents; D002791:Cholesterol, Dietary; D008055:Lipids; D002807:Chondroitin; D002784:Cholesterol